Nutriband selects commercial brand name for abuse deterrent fentanyl patch, submits to FDA for approval.
ByAinvest
Monday, Mar 30, 2026 4:07 pm ET1min read
NTRB--
Nutriband has selected a commercial brand name for its abuse deterrent fentanyl patch, which will be submitted to the FDA for approval. The company partnered with Brand Institute, Inc. to develop the worldwide brand name and visual identity for the product. The selected name is being submitted to the US Patent and Trademark Office for trademark registration and has the potential to reach peak annual US sales of $80 million to $200 million.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet